Provided by Tiger Fintech (Singapore) Pte. Ltd.

Black Diamond Therapeutics, Inc.

2.75
-0.1000-3.51%
Post-market: 2.750.00000.00%19:47 EDT
Volume:565.61K
Turnover:1.55M
Market Cap:156.57M
PE:10.99
High:2.85
Open:2.85
Low:2.69
Close:2.85
52wk High:6.33
52wk Low:1.20
Shares:56.94M
Float Shares:39.24M
Volume Ratio:0.78
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2503
EPS(LYR):-1.2662
ROE:11.85%
ROA:3.02%
PB:1.18
PE(LYR):-2.17

Loading ...

Black Diamond Theraptcs Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 11

Black Diamond Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $10 From $12

THOMSON REUTERS
·
Aug 11

Black Diamond Therapeutics Q2 net loss narrows as costs drop

Reuters
·
Aug 07

Black Diamond Therapeutic Q2 EPS $(0.19) Beats $(0.22) Estimate

Benzinga
·
Aug 07

Black Diamond Therapeutics Q2 Basic EPS USD -0.19

THOMSON REUTERS
·
Aug 07

Black Diamond Therapeutics Q2 Cash & Investments USD 142.8 Million

THOMSON REUTERS
·
Aug 07

Black Diamond Therapeutics Q2 Income From Operations USD -13.42 Million

THOMSON REUTERS
·
Aug 07

Black Diamond Therapeutics Inc - Q2 EPS $-0.19

THOMSON REUTERS
·
Aug 07

Black Diamond Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
Aug 01

Black Diamond, Nike, Apple, Block, IonQ: Trending by Analysts

TIPRANKS
·
Jul 05

Black Diamond Theraptcs Price Target Announced at $11.00/Share by Raymond James

Dow Jones
·
Jul 01

Black Diamond Therapeutics Inc. Conducted Virtual Annual Meeting

Reuters
·
Jun 13

Black Diamond Therapeutics Inc. to Participate in Jefferies Global Healthcare Conference

Reuters
·
May 29

Black Diamond Therapeutics reports Q1 diluted EPS 98c vs. (35c) last year

TIPRANKS
·
May 13

Black Diamond Therapeutic Q1 EPS $0.98 Beats $0.02 Estimate, Sales $70.00M

Benzinga
·
May 13

Black Diamond Therapeutics Reports Q1 2025 Results: Net Income Surges to $56.5M, R&D Expenses Decrease

Reuters
·
May 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Black Diamond Therapeutics Inc expected to post earnings of 20 cents a share - Earnings Preview

Reuters
·
May 05

Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year

Simply Wall St.
·
May 04

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Mar 31